Digital AI-powered drug discovery is outpacing regulators, with Eric... During the AAPS National Biotech Conference 2025, pharmaphorum’s Jonah Comstock sat down with Eric Luellen, the founder and CTIO of Turing Biosciences
Digital Sponsored Axtria Ignite 2025: AI-powered pharma leadership and transfo... Axtria, an AI-first data analytics innovator focused on transforming life sciences, has announced its highly anticipated Axtria Ignite 2025 conference, set to take place 4th-5th June at the
Digital From signatures to success: How digital consent accelerates ... Informed consent is a foundational element of every clinical trial.
Digital AI in drug development: The real hurdle is implementation Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.
Digital Sponsored 12 Questions with Michael Müller-Peltzer Michael Müller-Peltzer leads the European strategy for Vault CRM Campaign Manager at Veeva Systems.
Digital Patients as active consumers of care: AI-driven personalisat... In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.
News SpliceBio gathers $135m for eye disease gene therapies Spain's SpliceBio has raised $135m in financing that will help it move a gene-editing therapy for Stargardt disease through clinical testing.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face